LM

Lewis Markoff

US US Dept of Health & Human Services: 4 patents #256 of 3,044Top 9%
📍 Bethesda, MD: #239 of 2,269 inventorsTop 15%
🗺 Maryland: #3,562 of 35,612 inventorsTop 15%
Overall (All Time): #553,448 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11753627 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Brian R. Murphy, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2023-09-12
10837003 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Stephen S. Whitehead, Brian R. Murphy, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2020-11-17
RE46641 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Brian R. Murphy, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-12-19
RE46631 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Brian R. Murphy, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-12-12
9783787 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 Stephen S. Whitehead, Brian R. Murphy, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley +1 more 2017-10-10
8075903 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 Stephen S. Whitehead, Brian R. Murphy, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley 2011-12-13
7851194 West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines Li-Wei Yu 2010-12-14
7517531 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 Stephen S. Whitehead, Brian R. Murphy, Barry Falgout, Joseph E. Blaney, Kathryn A. Hanley 2009-04-14
6685948 Replication-defective dengue viruses that are replication-defective in mosquitoes for use as vaccines Lingling ZENG 2004-02-03